G

Guobang Pharma Ltd
SSE:605507

Watchlist Manager
Guobang Pharma Ltd
SSE:605507
Watchlist
Price: 20.51 CNY -2.66% Market Closed
Market Cap: 11.4B CNY
Have any thoughts about
Guobang Pharma Ltd?
Write Note

Relative Value

The Relative Value of one Guobang Pharma Ltd stock under the Base Case scenario is 35.37 CNY. Compared to the current market price of 20.51 CNY, Guobang Pharma Ltd is Undervalued by 42%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
35.37 CNY
Undervaluation 42%
Relative Value
Price
G
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
63
vs Industry
56
Median 3Y
2.1
Median 5Y
2.1
Industry
2.6
Forward
1.7
vs History
34
vs Industry
29
Median 3Y
16
Median 5Y
16
Industry
23
Forward
11.7
vs History
9
vs Industry
10
Median 3Y
17.1
Median 5Y
17.1
Industry
17.8
vs History
vs Industry
10
Median 3Y
-12.2
Median 5Y
-12.2
Industry
25.4
vs History
70
vs Industry
53
Median 3Y
1.7
Median 5Y
1.7
Industry
2.2
vs History
56
vs Industry
56
Median 3Y
2
Median 5Y
2
Industry
2.8
Forward
1.7
vs History
39
vs Industry
27
Median 3Y
8.1
Median 5Y
8.1
Industry
5.4
vs History
24
vs Industry
24
Median 3Y
13.9
Median 5Y
13.9
Industry
13.7
Forward
6.7
vs History
24
vs Industry
29
Median 3Y
13.9
Median 5Y
13.9
Industry
17.2
vs History
9
vs Industry
10
Median 3Y
16.8
Median 5Y
16.8
Industry
16.5
vs History
vs Industry
11
Median 3Y
-22.3
Median 5Y
-22.3
Industry
19.3
vs History
70
vs Industry
51
Median 3Y
1.9
Median 5Y
1.9
Industry
2

Multiples Across Competitors

Competitors Multiples
Guobang Pharma Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Guobang Pharma Ltd
SSE:605507
11.3B CNY 2.1 17.2 15.9 15.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
756.5B USD 18.5 90.4 48.6 54.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
364.1B USD 4.2 24.8 12 15.6
US
Merck & Co Inc
NYSE:MRK
248.4B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
208.5B CHF 3.6 18.1 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.5 169.4 253.8
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
CN
G
Guobang Pharma Ltd
SSE:605507
Average P/E: 31.3
17.2
132%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.4
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
24.8
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.1
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top